Moneycontrol Be a Pro
Get App
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > Pharmaceuticals > Profit & Loss account - Divis Laboratories

Divis Laboratories

BSE: 532488|NSE: DIVISLAB|ISIN: INE361B01024|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Dec 06, 15:40
1783.25
-18.35 (-1.02%)
VOLUME 20,208
LIVE
NSE
Dec 06, 15:57
1783.85
-17.65 (-0.98%)
VOLUME 541,954
Download Annual Report PDF Format 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010

Profit & Loss account of Divis Laboratories

------------------- in Rs. Cr. -------------------
Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
12 mths 12 mths 12 mths 12 mths 12 mths
INCOME
Revenue From Operations [Gross] 4,737.22 3,753.19 4,054.74 3,742.48 3,099.24
Less: Excise/Sevice Tax/Other Levies 0.00 21.29 41.93 28.52 26.94
Revenue From Operations [Net] 4,737.22 3,731.90 4,012.81 3,713.96 3,072.30
Other Operating Revenues 142.44 84.04 11.04 7.37 11.71
Total Operating Revenues 4,879.66 3,815.94 4,023.85 3,721.33 3,084.01
Other Income 156.58 112.48 75.94 94.40 42.84
Total Revenue 5,036.24 3,928.42 4,099.79 3,815.73 3,126.85
EXPENSES
Cost Of Materials Consumed 2,082.05 1,524.28 1,563.19 1,472.43 1,446.27
Changes In Inventories Of FG,WIP And Stock-In Trade -244.22 -19.38 -21.61 23.27 -230.83
Employee Benefit Expenses 530.72 446.27 490.33 357.36 283.15
Finance Costs 3.50 1.33 2.25 2.32 1.86
Depreciation And Amortisation Expenses 168.81 142.42 123.26 118.10 135.85
Other Expenses 662.15 614.14 554.14 470.40 423.37
Total Expenses 3,203.01 2,709.06 2,711.56 2,443.89 2,059.67
Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
12 mths 12 mths 12 mths 12 mths 12 mths
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax 1,833.23 1,219.36 1,388.23 1,371.84 1,067.18
Profit/Loss Before Tax 1,833.23 1,219.36 1,388.23 1,371.84 1,067.18
Tax Expenses-Continued Operations
Current Tax 472.45 287.13 285.23 283.00 216.20
Less: MAT Credit Entitlement 0.00 0.00 0.00 36.12 7.35
Deferred Tax 28.13 62.65 49.73 16.75 10.78
Tax For Earlier Years 0.00 0.00 0.00 0.52 0.49
Total Tax Expenses 500.58 349.78 334.96 264.14 220.12
Profit/Loss After Tax And Before ExtraOrdinary Items 1,332.65 869.58 1,053.27 1,107.69 847.06
Profit/Loss From Continuing Operations 1,332.65 869.58 1,053.27 1,107.69 847.06
Profit/Loss For The Period 1,332.65 869.58 1,053.27 1,107.69 847.06
Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
12 mths 12 mths 12 mths 12 mths 12 mths
OTHER ADDITIONAL INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.) 50.20 32.76 39.68 41.73 63.82
Diluted EPS (Rs.) 50.20 32.76 39.68 41.73 63.82
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS
Imported Raw Materials 0.00 0.00 0.00 803.37 722.51
Indigenous Raw Materials 0.00 0.00 0.00 669.06 723.77
STORES, SPARES AND LOOSE TOOLS
Imported Stores And Spares 0.00 0.00 0.00 1.90 2.53
Indigenous Stores And Spares 0.00 0.00 0.00 17.09 13.52
DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend 265.47 265.47 0.00 265.47 265.47
Tax On Dividend 54.57 54.04 0.00 54.04 54.04
Equity Dividend Rate (%) 800.00 500.00 500.00 500.00 1,000.00
Source : Dion Global Solutions Limited

Results of Pharmaceuticals Sector

  • News
  • Results
  • Estimates
  • Analysis
No news.
Quick Links for divislaboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.